Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patients

• Published in: OncoTargets and therapy Vol. 7; pp. 1301 - 1310
• Main Authors: Zhao, Hong-Yun, Ma, Guo-Wei, Zou, Ben-Yan, Li, Mei, Lin, Su-Xia, Zhao, Li-Ping, Guo, Ying, Huang, Yan, Tian, Ying, Xie, Dan, Zhang, Li
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2014; Dove Press; Dove Medical Press
• Subjects: Care and treatment; Enzymes; Genetic aspects; Lung cancer, Non-small cell; Methods; Original Research; orotate phosphoribosyltransferase; Postoperative care; Regulation; thymidine phosphorylase; orotate phosphoribosyltransferase; thymidine phosphorylase
• ISSN: 1178-6930; 1178-6930
• DOI: 10.2147/ott.s65067

The aim of the present study was to investigate the clinicopathologic/prognostic significance of thymidylate synthase (TS), orotate phosphoribosyltransferase (OPRT), and thymidine phosphorylase (TP) proteins in postoperative non-small cell lung cancer (NSCLC) patients. Microarray slides from a set of 178 NSCLC patients were used for the detection of TS, OPRT, and TP expression by immunohistochemistry. The correlation between clinicopathologic factors and protein expression of three proteins was analyzed. Ninety seven carcinomas (57.4%) were TS-positive, 90 carcinomas (53.9%) were OPRT-positive, and 102 carcinomas (69.4%) were TP-positive. Compared with the TS-positive patients, the overall survival (OS) was significantly lower in the TS-negative patients (hazard ratio [HR] =1.766, 95% confidence interval [CI] =1.212-2.573, P=0.003). Significant differences between TS-positive and TS-negative patients was also observed in the following stratified analyses: 1) adenocarcinoma subgroup (HR =2.079, 95% CI =1.235-3.500, P=0.006); 2) less than 60-year-old subgroup (HR =1.890, 95% CI =1.061-3.366, P=0.031); 3) stage II/III subgroup (HR =1.594, 95% CI =1.036-2.453, P=0.034); and 4) surgery plus adjuvant therapy subgroup (HR =1.976, 95% CI =1.226-3.185, P=0.005). However, the OS was not significantly correlated with OPRT or TP protein expression. This study demonstrates that the TS level in tumor tissues may be a useful marker to predict the postoperative OS in NSCLC patients.